High-risk extranodal natural killer/T-cell lymphoma patients could benefit more from allogeneic hematopoietic stem cell transplantation as consolidation: A real-world multicenter analysis in China
摘要： Objective: Both allogeneic hematopoietic stem cell transplantation(allo-HSCT) and autologous HSCT(ASCT)are important therapies for extranodal natural killer/T-cell lymphoma(ENKTCL); however,... ...
（共19页）
开通会员，享受整站包年服务
说明： 本文档由创作者上传发布，版权归属创作者。若内容存在侵权，请点击申诉举报
APP